title: Therapy of multiple myeloma. Italian Multiple Myeloma Study Group.
authors.affiliation: Catedra di Ematologia, Turin, Italie.
authors.forename: M
authors.initials: M
authors.lastname: Boccadoro
authors.forename: G
authors.initials: G
authors.lastname: Avvisati
authors.forename: M
authors.initials: M
authors.lastname: Cantonetti
authors.forename: B M
authors.initials: BM
authors.lastname: Cavo-Comotti
authors.forename: R
authors.initials: R
authors.lastname: Frieri
authors.forename: A
authors.initials: A
authors.lastname: Gallamini
authors.forename: G
authors.initials: G
authors.lastname: Gallone
authors.forename: V M
authors.initials: VM
authors.lastname: Lauta
authors.forename: M
authors.initials: M
authors.lastname: Liberati
authors.forename: F
authors.initials: F
authors.lastname: Marmont
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002330:Carmustine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008558:Melphalan / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000401:mortality / Q000628:therapy*; D011241:Prednisone / Q000627:therapeutic use; D011994:Recombinant Proteins; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D008558:Melphalan; D002330:Carmustine; D011241:Prednisone